Combination Cancer Therapy Comprising Administration of an EGFR Inhibitor and an IGF-1R Inhibitor

• 收藏
• 分享

专利权人:

Maryland Franklin

发明人:

Maryland Franklin,Robert Wild

申请号：

US13256766

公开号：

US20120064072A1

申请日:

2010.03.18

申请国别(地区):

US

年份:

2012

代理人:

摘要：

A method of treating cancer comprising: (a) identifying a patient having cancer that initially responded to IRS1 agent therapy and that has resumed progression (b) administering an effective regimen comprising the same or a different IRS1 agent and an IGF-1 R inhibitor administered together or sequentially.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/